Home Cart Sign in  
Chemical Structure| 2166387-64-8 Chemical Structure| 2166387-64-8

Structure of BI-3812
CAS No.: 2166387-64-8

Chemical Structure| 2166387-64-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BI-3812 is a BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of ≤3 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BI-3812

CAS No. :2166387-64-8
Formula : C26H32ClN7O5
M.W : 558.03
SMILES Code : O=C(C1CCN(C2=NC=C(Cl)C(NC3=CC4=C(N(C)C(C(OCC(NC)=O)=C4)=O)C(OC)=C3)=N2)CC1)N(C)C
MDL No. :MFCD31657385
InChI Key :XCGYXEVLQIIEJH-UHFFFAOYSA-N
Pubchem ID :134691741

Safety of BI-3812

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
COS-7 cells 1 μM Test the dissolution effect of BI-3812 on BTB-mCh, no condensates formed Nat Chem Biol. 2024 Apr;20(4):452-462
COS-7 cells 1 μM Test the dissolution effect of BI-3812 on different BTB configurations, results showed BI-3812 can rapidly dissolve condensates Nat Chem Biol. 2024 Apr;20(4):452-462
MCF10A cells 1 μM 10 min To evaluate the phosphorylation and downstream signaling activation of the EGFR-BTB BCL6 fusion protein. Results showed that BI-3802 treatment increased phosphorylation of EGFR-BTB BCL6 and its downstream effectors MEK1/2 and ERK1/2. Cell Rep Methods. 2022 Apr 13;2(4):100193
HEK293T cells 1 μM 3 days To assess the stability and oligomerization capability of the EGFP-BTB BCL6 fusion protein. Results showed that EGFP-BTB BCL6 formed stable cytoplasmic foci upon BI-3802 treatment without degradation. Cell Rep Methods. 2022 Apr 13;2(4):100193

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.79mL

0.36mL

0.18mL

8.96mL

1.79mL

0.90mL

17.92mL

3.58mL

1.79mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories